We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $3.38B
1-Year Est. Return 214.12%
This Fund
S&P 500
This Quarter Est. Return
+62.53%
1 Year Est. Return
+214.12%
3 Year Est. Return
+1,162.23%
5 Year Est. Return
+1,566.59%
10 Year Est. Return
–
AUM
$1.73B
AUM Growth
+$568M
Cap. Flow
+$204M
Cap. Flow %
11.79%
Top 10 Hldgs %
55.41%
Holding
127
New
20
Increased
32
Reduced
36
Closed
35

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$82M
2
TSM icon
TSMC
TSM
+$49M
3
SOFI icon
SoFi Technologies
SOFI
+$48.2M
4
AMZN icon
Amazon
AMZN
+$43.1M
5
AMD icon
Advanced Micro Devices
AMD
+$33.5M

Top Sells

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$53.8M
2
OSCR icon
Oscar Health
OSCR
+$52.9M
3
GRND icon
Grindr
GRND
+$43.3M
4
BBIO icon
BridgeBio Pharma
BBIO
+$19.6M
5
HIMS icon
Hims & Hers Health
HIMS
+$17.7M

Sector Composition

Rank Sector Weight
1 Financials 34.06%
2 Technology 29.84%
3 Miscellaneous 11.48%
4 Consumer Discretionary 11.33%
5 Healthcare 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
76
IDEAYA Biosciences
IDYA
$3.85B
$88.7K 0.01%
4,220
-38,495
-90% -$739K
ARGX icon
77
argenx
ARGX
$64.6B
$87.1K 0.01%
158
-1,689
-91% -$980K
RARE icon
78
Ultragenyx Pharmaceutical
RARE
$1.51B
$74.7K ﹤0.01%
2,055
-19,600
-91% -$707K
AGIO icon
79
Agios Pharmaceuticals
AGIO
$1.98B
$74.2K ﹤0.01%
2,230
-19,238
-90% -$583K
RVMD icon
80
Revolution Medicines
RVMD
$45B
$71.9K ﹤0.01%
1,955
-3,089
-61% -$119K
IMCR icon
81
Immunocore
IMCR
$1.86B
$68.3K ﹤0.01%
2,176
-38,611
-95% -$1.2M
AKRO
82
DELISTED
Akero Therapeutics
AKRO
$67.3K ﹤0.01%
1,261
-3,176
-72% -$144K
ELVN icon
83
Enliven Therapeutics
ELVN
$4.35B
$63.8K ﹤0.01%
3,181
-16,205
-84% -$307K
BEAM icon
84
Beam Therapeutics
BEAM
$3.06B
$61.3K ﹤0.01%
3,603
-12,168
-77% -$212K
ANAB icon
85
AnaptysBio
ANAB
$1.68B
$60.1K ﹤0.01%
2,706
-22,716
-89% -$475K
DAWN
86
DELISTED
Day One Biopharmaceuticals
DAWN
$54.7K ﹤0.01%
8,413
-108,152
-93% -$744K
ATAI icon
87
AtaiBeckley Inc
ATAI
$2.74B
$50.8K ﹤0.01%
23,218
-415,889
-95% -$746K
VRDN icon
88
Viridian Therapeutics
VRDN
$2.6B
$49.4K ﹤0.01%
3,533
-68,147
-95% -$925K
CYTK icon
89
Cytokinetics
CYTK
$10.1B
$41.4K ﹤0.01%
+1,254
New +$43.6K
FULC icon
90
Fulcrum Therapeutics
FULC
$294M
$33.2K ﹤0.01%
+4,832
New +$25.8K
TRVI icon
91
Trevi Therapeutics
TRVI
$2.46B
$27.9K ﹤0.01%
5,106
-36,881
-88% -$229K
MU icon
92
CALL
Micron Technology
MU
$1.15T
$24.6K ﹤0.01%
200
-72,800
-100% -$6.8M
AAPL icon
93
Apple
AAPL
$4.67T
– –
-1,256
Closed -$279K
AMZN icon
94
CALL
Amazon
AMZN
$2.79T
– –
-57,500
Closed -$10.9M
AUTL
95
Autolus Therapeutics
AUTL
$596M
– –
-199,359
Closed -$309K
BABA icon
96
CALL
Alibaba
BABA
$281B
– –
-12,500
Closed -$1.65M
CMPS
97
Compass Pathways
CMPS
$1.84B
– –
-246,320
Closed -$704K
COIN icon
98
PUT
Coinbase
COIN
$48.7B
– –
-267,500
Closed -$46.1M
CVNA icon
99
CALL
Carvana
CVNA
$53.7B
– –
-50,000
Closed -$2.09M
DUOL icon
100
CALL
Duolingo
DUOL
$7.23B
– –
-7,500
Closed -$2.33M
2 3
4
5 6

Similar funds

MCM
Militia Capital Management Austin, Texas $3.37B AUM
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.37B AUM 20.71% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.37B AUM 30.24% 1-Year Est. Return
SGI
Swan Global Investments Durango, Colorado $3.39B AUM 20.1% 1-Year Est. Return
EG
Electrum Group New York $3.39B AUM
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
EC
Elequin Capital New York $3.36B AUM 11.23% 1-Year Est. Return

BIT Capital's Q2 2025 Portfolio in Review

As of Q2 2025, BIT Capital held 127 positions worth $1.73B, up 49% from $1.17B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

BIT Capital deployed $204M of net new capital in Q2 2025, opening 20 new positions and adding to 32 existing holdings. Its largest new stake was Hinge Health: 756,204 shares worth $39.1M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 21% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Duolingo, an estimated $53.8M trimmed.

  • BIT Capital's largest Q2 2025 buy was Hinge Health: 756,204 shares worth $39.1M.
  • BIT Capital added most to NVIDIA in Q2 2025, an estimated $82M increase.
  • BIT Capital's biggest Q2 2025 reduction was Duolingo, cutting an estimated $53.8M.
  • BIT Capital fully exited Reddit in Q2 2025, selling an estimated $11.7M.
  • BIT Capital's ten largest holdings make up 55% of its $1.73B portfolio in Q2 2025.
  • BIT Capital opened 20 new positions and closed 35 in Q2 2025.
  • BIT Capital's portfolio value rose 49% quarter-over-quarter to $1.73B.

Based on BIT Capital's 13F filing for Q2 2025, filed 8 Aug 2025.